Moderna
MRNA
#1301
Rank
HK$107.54 B
Marketcap
HK$279.46
Share price
5.37%
Change (1 day)
-64.14%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

EPS for Moderna (MRNA)

EPS in 2023 (TTM): -HK$71.67

According to Moderna 's latest financial reports the company's current EPS (TTM) is -HK$71.17. In 2022 the company made an earnings per share (EPS) of HK$164.45 a decrease over its 2021 EPS that were of HK$235.78.

EPS history for Moderna from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$71.67-143.58%
2022HK$164.45-30.25%
2021HK$235.78-1660.82%
2020-HK$15.1125.16%
2019-HK$12.0737.04%
2018-HK$8.81

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-HK$13.16-81.51%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$14.18-119.93%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$23.59-66.85%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$32.00-55.03%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$29.12-140.92%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-HK$13.24-81.40%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$109.68-254.11%๐Ÿ‡บ๐Ÿ‡ธ USA